Browsing: Biotech Investment Therapeutics

South African biotech startup Immobazyme has significantly scaled its financial foundation by securing an additional R25 million ($1.45 million) in…

South African biotech startup Immobazyme has successfully secured an additional R25 million ($1.45 million) in growth funding, which doubles its…